Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: TC Jefferson, The Plenum Group

    Longevity and Mortality Risk Transfer April 10, 2024By Greg Winterton
    Share
    Twitter LinkedIn Email

    It’s well documented that the pension risk transfer (PRT) market in the UK has a human capital problem, in the sense that there aren’t enough people to fill the vacancies in the space. Greg Winterton spoke to TC Jefferson, Managing Partner at executive search firm The Plenum Group, to learn more about the going on in the space. 

    GW: TC, there is plenty of coverage in the trade media about this apparent ‘challenge’ that firms in the pension risk transfer market face when it comes to hiring. Just how ‘real’ is this issue? 

    TCJ: Thanks Greg. I can assure you this problem is very real. You only need to look at the volume of deals that happened last year and predictions for this year to know that there is a challenge. Plenum has been working in the pension risk transfer market for many years, but the last six months has seen us spending almost all of our time in this space to try to fill an unprecedented number of vacancies. 

    GW: Which firms are more impacted – is it the insurers, or the consulting firms, and why? 

    TCJ: Both are struggling to find and also retain the right people. However, the problem is probably more acutely felt on the consulting side. This tends to be because individuals that work on the provider side feel more at home executing the deals rather than acting as a broker. Similarly, many on the consulting side see little merit in moving to another consulting team that they think might feel very similar to where they are now. What we often hear from consultants is that they would only consider a move if it was to a provider. 

    GW: Are there any specific roles that are seeing higher demand than others?  

    TCJ: There are number of functions that can quite easily scale in this industry, with perhaps investment teams and operational teams having the most to gain here. However, it tends to be the pricing area as well as “deal champion” and business development that is hardest to scale. The demand is not equally spread across levels either. Whilst we typically specialise in more senior hires, we have seen a number of consulting houses repeat requests for individuals at the mid-level, with a few years of PRT deal experience under their belt. Such people are currently like gold dust, with packages rising rapidly, and arguably, unsustainably. 

    GW: Aside from financial compensation, what are some of the other benefits that hiring companies can offer to sweeten the deal? Is working from home seen to be a plus to job seekers, for example? 

    TCJ: The financial side is obviously important, but it’s not the only factor. Even within the financial side, it’s not all about pure salary. Bonus plays a significant role as does the willingness of firms to buy individuals out of any accrued bonus as well as offering any stock options or long-term incentive plan. Career development is also incredibly important with many people citing that they would only move for a “head of” position or significant step up in responsibility.  

    Soft benefits like working from home do make a difference, yes. Whilst much of the pension risk transfer business is in London, there are hubs elsewhere, both in the south and east of England, as well as into the midlands and the north. The ability for those individuals to move up the career ladder without having to relocate to London can be very appealing and smart teams are attracting people by offering this. 

    GW: Lastly, TC, what is the medium-term reality here for hiring companies? There are a lot of actuaries in this market, but it takes years for new actuaries to become qualified. It’s not like tech where you can learn a programming language quickly. 

    TCJ: Great question. I think ultimately, the industry is not going be able to have sufficient human capital to deliver on its growing requirements simply by pinching people from each other’s firms! Yes, it takes a long time to train an actuary, but I don’t think that really is the issue. There are a number of actuaries within the insurance sector who are seeing technology disrupt out of date working practices, potentially freeing up their time to spend on higher value tasks. However, probably more significant is the inverse decline in traditional pension consulting that mirrors the boom of PRT deals. As such, employee benefit consultancies have ample pension actuaries in a shrinking part of the business that can be redeployed into pension risk transfer teams; almost every employee benefit consultancy is doing this. The challenge, however, is that it takes time to get up to speed in PRT and get the requisite deal experience so that consultants can fly solo on these deals. 

    The consulting community has, to date, provided a significant proportion of the insurers’ pension risk transfer talent. We see no real reason why trend would not continue. 

    TC Jefferson is Managing Partner at The Plenum Group 

    2024 - April Longevity Risk Pension Risk Transfer Q&A Volume 3 Issue 4 - April 2024
    Share. Twitter LinkedIn Email

    Related Posts

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026By Greg Winterton

    Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

    August 5, 2026By LMI Newsdesk

    Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 3, 2026By LMI Newsdesk

    Lincoln Financial Reinsures Universal Life Block With Talcott

    August 3, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.